![Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far? | ACS Omega Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far? | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.2c07326/asset/images/large/ao2c07326_0002.jpeg)
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far? | ACS Omega
![FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks | Science Advances FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks | Science Advances](https://www.science.org/cms/10.1126/sciadv.adf4409/asset/c177fd84-955d-4d5c-8257-d3df852a026e/assets/images/large/sciadv.adf4409-f4.jpg)
FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks | Science Advances
![FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks | Science Advances FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks | Science Advances](https://www.science.org/cms/10.1126/sciadv.adf4409/asset/c445a5d9-79c4-4751-aac1-07cb56bb520e/assets/images/large/sciadv.adf4409-f1.jpg)
FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks | Science Advances
![FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks | Science Advances FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks | Science Advances](https://www.science.org/cms/10.1126/sciadv.adf4409/asset/6fbef567-6922-465b-9905-f2a233fc4234/assets/images/large/sciadv.adf4409-f2.jpg)
FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks | Science Advances
![Pharmaceutics | Free Full-Text | Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design Pharmaceutics | Free Full-Text | Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-13-01879/article_deploy/html/images/pharmaceutics-13-01879-ag.png?1636125901)
Pharmaceutics | Free Full-Text | Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
![JPM | Free Full-Text | Machine Learning-Based Approach Highlights the Use of a Genomic Variant Profile for Precision Medicine in Ovarian Failure JPM | Free Full-Text | Machine Learning-Based Approach Highlights the Use of a Genomic Variant Profile for Precision Medicine in Ovarian Failure](https://www.mdpi.com/jpm/jpm-11-00609/article_deploy/html/images/jpm-11-00609-g001.png)
JPM | Free Full-Text | Machine Learning-Based Approach Highlights the Use of a Genomic Variant Profile for Precision Medicine in Ovarian Failure
![IJERPH | Free Full-Text | Cannabis- and Substance-Related Epidemiological Patterns of Chromosomal Congenital Anomalies in Europe: Geospatiotemporal and Causal Inferential Study IJERPH | Free Full-Text | Cannabis- and Substance-Related Epidemiological Patterns of Chromosomal Congenital Anomalies in Europe: Geospatiotemporal and Causal Inferential Study](https://pub.mdpi-res.com/ijerph/ijerph-19-11208/article_deploy/html/images/ijerph-19-11208-g004.png?1662608086)